NEWS

By: UNAIDS – https://www.unaids.org/en/resources/presscentre/featurestories/2019/june/20190626_cs-uhc Achieving universal health coverage in a country is an ambitious but transformative goal. Communities are essential to the AIDS response and will be essential to the successful rollout of universal health coverage (UHC). When national governments establish a committee to coordinate universal health coverage, it is […]

By: Jorge Galindo – https://elpais.com/internacional/2019/06/21/america/1561126403_693676.html We cannot underestimate the importance and potential of counter-majoritarian institutions for the advancement of LGBT rights in Latin America. Unequal. That is the appropriate adjective to describe the situation of LGBT rights in Latin America and the Caribbean. The part of daily life that depends on the

By: Michael Carter – http://www.aidsmap.com/page/3536944/ According to doctors reporting at the Infectious Diseases Open Forum, hair loss (alopecia) occurred in six African American women living with HIV after switching to the new formulation of tenofovir. The clinical trials that led to the approval of tenofovir alafenamide in 2015 did not identify hair loss as a side effect.

By: MDZ WORLD – https://www.mdzol.com/mundo/argentina-desarrolla-nuevo-tratamiento-para-el-vih-de-que-se-trata-20190626-33782.html Richmond Laboratories announced the launch of ZEVUVIR, a drug whose objective is to delay the progression of the virus in patients. Richmond Laboratories, one of the leading suppliers of oncology and HIV-related medications in Argentina, announced on Monday the launch of ZEVUVIR, a drug that seeks to delay

By Linet Imbosa Muhati-Nyakundi, https://medicalxpress.com/news/2019-06-preschools-children-hiv.html Thanks to antiretroviral therapy, children living with HIV are likely to live much longer than they would without treatment. They will go to school like other children and develop in the same way. But how much do their teachers and classmates need to know about their HIV-positive status? And what

By: Michael Carter – http://www.aidsmap.com/page/3535508/ No HIV infections occurred during the two-year follow-up period among people who received pre-exposure prophylaxis (PrEP) in a study conducted in Amsterdam, researchers report in Lancet HIV. The study recruited men who have sex with men and transgender people who were

By Westmead Institute for Medical Research https://medicalxpress.com/news/2019-06-newly-immune-cells-frontline-hiv.html Researchers at the Westmead Institute for Medical Research have discovered new immune system cells that are on the front line of HIV infection. Known as CD11c+ dendritic cells, these new cells are more susceptible to HIV infection and can then transmit the virus to